Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 Black Phoenix Black Phoenix +336.77%
#4 aPriori aPriori +120.78%
#5 Bedrock Bedrock +76.11%
#6 Cysic Cysic +49.09%
#7 Prom Prom +41.94%
#8 Playnance Playnance +35.13%
#9 COTI COTI +25.33%
#10 Nillion Nillion +24.72%
Coin of the day
Wrapped One Wrapped One
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NOVO-B
Classificação em ações #88
Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the... Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the innovation, development, production, and commercialization of pharmaceutical solutions. Its business is primarily divided into two key segments: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care segment offers a comprehensive portfolio of treatments for diabetes (including insulins, GLP-1 analogues, oral antidiabetic agents, and related delivery systems), obesity management, glucagon, medical needles, and other chronic conditions. The Rare Disease segment provides specialized medications for haemophilia, various blood disorders, endocrine imbalances, growth hormone deficiencies, and hormone replacement therapy. Additionally, the company engages in strategic alliances, including a partnership with Gilead Sciences, Inc., and conducts research focused on identifying cell-specific carriers for nucleic acid-based therapies. Established in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.
Preço da ação
$47.55
Valor de mercado
$211.25B
Variação (1 dia)
-2.51%
Variação (1 ano)
-5.18%
País
DK
Negociar Novo Nordisk A/S (NOVO-B)

Categoria

Healthcare
Rácio P/S de Novo Nordisk A/S (NOVO-B)
Rácio P/S em February 2026 TTM: 4.47
De acordo com os relatórios financeiros mais recentes e o preço das ações da Novo Nordisk A/S, o rácio P/S atual (TTM) é 4.47. No final de 2026, o rácio P/S era 0.
Histórico do rácio P/S da Novo Nordisk A/S de 2026 a 2026
Rácio P/S no final de cada ano
Ano Rácio P/S Alterar
Não há dados suficientes para as datas fornecidas.
Rácio P/S de empresas semelhantes ou concorrentes
Empresa Rácio P/S Diferença do rácio P/S País
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
14.97 235.27%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
6.31 41.28%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
7.06 58.02%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
4.66 4.33%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
4.90 9.81%
US